Aurinia Pharmaceuticals Inc. reports

Company location: Edmonton, Alberta, Canada
Fiscal year end: 31 December

Aurinia Pharmaceuticals Inc. has filed 606 SEC EDGAR filings since 28 Feb 2014

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G
40-F
6-K

SEC filing history

Showing 476-500 of 606 matching filings.

Per page

Current page

6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date: 16 Mar 2017
Reporting date: 16 Mar 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36421

FORM 6-K

Filing date: 16 Mar 2017
Reporting date: 14 Mar 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

SUPPL File 333-206994

SUPPL

Filing date: 14 Mar 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date: 14 Mar 2017
Reporting date: 14 Mar 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

FWP File 333-206994

FWP

Filing date: 14 Mar 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SUPPL File 333-206994

SUPPL

Filing date: 13 Mar 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date: 13 Mar 2017
Reporting date: 13 Mar 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36421

FORM 6-K

Filing date: 09 Mar 2017
Reporting date: 08 Mar 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

40-F File 001-36421

FORM 40-F

Filing date: 09 Mar 2017
Reporting date: 31 Dec 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date: 09 Mar 2017
Reporting date: 09 Mar 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date: 06 Mar 2017
Reporting date: 06 Mar 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

S-8 File 333-216447

FORM S-8

Filing date: 03 Mar 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date: 02 Mar 2017
Reporting date: 02 Mar 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date: 02 Mar 2017
Reporting date: 02 Mar 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date: 01 Mar 2017
Reporting date: 01 Mar 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

SUPPL File 333-206994

SUPPL

Filing date: 24 Feb 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date: 16 Feb 2017
Reporting date: 16 Feb 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-88628

SC 13G/A filing

Filing date: 14 Feb 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date: 14 Feb 2017
Reporting date: 14 Feb 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date: 07 Feb 2017
Reporting date: 27 Jan 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date: 06 Feb 2017
Reporting date: 06 Feb 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date: 26 Jan 2017
Reporting date: 26 Jan 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D File 005-88628

GROWTH EQUITY OPPORTUNITIES FUND III, LLC / AURINIA PHARMACEUTICALS INC.

Filing date: 09 Jan 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A File 005-88628

FORM SC 13D/A

Filing date: 05 Jan 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date: 03 Jan 2017
Reporting date: 03 Jan 2017
SEC evidence: Open document Open filing
Next action: Verify source filing